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Effect of Maximal Medical Therapy on 
Refractoriness of Unstable Angina Pectoris 
David W. Grambow, MD, and Eric J. Topol, MD 
A group of 125 patients with unstable angina 
were studied over a S-year period to define the in- 
cidence of refractory unstable angina in the cur- 
rent era of S-drug medical therapy with intrave- 
nous heparht, aspirin, nitrates, caldum antago- 
nists and fl blockers. All patients had >26 minutes 
of chest pain at rest with reversible ekctrocardio- 
graphic changes occurring in the absence of myo- 
cardial infarction. Patients were considered re- 
fractory only if chest pain continued despite treat- 
ment with maximal I-drug therapy. 
At the time of transfer to the center, 65 pa- 
tients continued to have ischemic chest pain at 
rest and were considered 66medically refractory” 
by their referring physicians. A more aggressive 
medical regimen was used, and 54 patients (63%) 
were rendered chest pain-free. Of the 11 truly re- 
fractory patients (8.8%), coronary artertography 
revealed an increased likelihood of left main or 3- 
vesset disease (7 of 11 vs 26 of 114; p = 0.01). In- 
hospital treatment strategies for the 114 patients 
stabilized with medical therapy included continued 
medkal therapy (n = 37), coronary angioptasty 
(n = 46) and bypass graftbrg (n = 31). The rate of 
myocardtal infarction or death in patients man- 
aged medkally was 3%. Coronary angioplasty in 
medkally stabtlized patients was complicated by 
an abrupt &sure rate of 26%, and a 17% rate of 
myocardial infarction, death or need for emergen- 
cy bypass graftbrg. Medically stabtlized pattents 
undergohtg bypass grafting had a 9% rate of myo- 
cardial infarction or death. Unstable angina truly 
refractory to current, maximal medkal therapy is 
infreuuent (8.8%). However, the refractory group 
is vulnerable to adverse angioplasty results and 
cardiac events. 
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nstable angina pectoris is responsible for U >750,000 hospitalizations annually in the Unit- ed States1 With conventional antianginal thera- 
py, up to 15% of patients develop myocardial infarction 
in the hospital.2 Recent studies suggest that routine use 
of intravenous heparin and aspirin signiticantly reduces 
morbidity and mortality in patients hospitalized with 
unstable angina. 3,4 Urgent revascularization by coro- 
nary angioplasty or bypass grafting has an increased 
complication rate in patients with unstable angina pec- 
toris.5,6 However, patients with unstable angina refrac- 
tory to medical therapy are at high risk for in-hospital 
cardiac events and should be most strongly considered 
for urgent revascularization. The incidence and out- 
comes of refractory unstable angina in the contempo- 
rary setting of maximal antianginal, antiplatelet and 
anticoagulant therapy is unknown. We sought to define 
the incidence of refractory unstable angina in a group of 
patients with unstable angina transferred to our tertiary 
care facility for consideration of coronary revasculariza- 
tion. 
METHODS . Sele&on of patie&sr Five hundred and two patients 
referred to the University of Michigan Hospital with 
the diagnosis of unstable angina between January 1, 
1986 and January 1, 1991 were analyzed retrospective- 
ly. Patients were included in the study provided that 
they: (1) were transferred from an outside hospital after 
being admitted with chest pain at rest of >20 min- 
utes duration; (2) had reversible electrocardiographic 
changes with chest pain, including >l mm ST-segment 
depression or elevation or T-wave inversion in 2 limb or 
contiguous precordial leads; (3) had peak creatine ki- 
nase levels <2 times the upper limits of normal; and (4) 
underwent an attempt at medical stabilization before 
transfer. 
One hundred twenty-five patients fulfilled the inclu- 
sion criteria and constituted the study population (Fig- 
ure 1). Baseline data abstracted from the clinical record 
on these patients included: (1) history of stable angina 
pectoris, myocardial infarction or congestive heart fail- 
ure; (2) history of myocardial revascularization; (3) 
character and location of electrocardiographic changes 
with chest pain; (4) medical regimen at transfer; (5) 
maximal medical regimen at University of Michigan; 
(6) duration of medical therapy before resolution of 
chest pain or before patient was considered refractory; 
and (7) results of cardiac catheterization including 
coronary anatomy (stenoses considered significant if 
270%) and left ventricular ejection fraction. 
Maximal medical therspy: Maximal medical thera- 
py was considered treatment with a combination of as- 
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TABLE I Characteristics of Patients with Refractory Unstable 
Angina and Those Stabilized with Medical Therapy 
Medically 
Refractory Stabilized 
(n = 11) (n = 114) p Value 
Age (year) 68+ 10 64~11 NS 
Male gender 7 (64%) 61 (54%) NS 
Prior stable angina 7 (64%) 83 (73%) NS 
Prior myocardial infarction 4 (36%) 48 (42%) NS 
Prior bypass coronary surgery 5 (45%) 20 (18%) 0.07 
Ejection fraction (%) 43 + 13 51 2 13 NS 
Duration of pain at rest (days) 924 4-t4 0.01 
ST-segment changes 
ST elevation 2 (18%) 11 (9%) NS 
ST depression 7 (64%) 42 (37%) NS 
T-wave inversion 2 (18%) 61 (54%) 0.05 
Anterior changes 7 (64%) 25 (22%) 0.008 
Inferior changes 0 43 (38%) 0.03 
Lateral changes 4 (36%) 46 (40%) NS 
Coronary anatomy 
Left main or 3-vessel disease 7 (64%) 26 (23%) 0.01 
l-to 2-vessel disease 4 (36%) 88 (77%) 0.01 
In-hospital death or myocardial 4 (36%) 9 (8%) 0.009 
infarction 
NS = not significant. 
pirin, intravenous heparin, nitrates, B blockers and calci- 
um antagonists. The number of these agents a patient 
was receiving was noted. Patients were considered to 
have true refractory unstable angina if chest pain at rest 
continued despite treatment with all 5 classes of medi- 
cation at maximal hemodynamically tolerated doses. 
Patknl groups: Patients were classified as medi- 
cally refractory if chest pain and electrocardiographic 
502 Pattents 
Transfer Diagnosis “Unstable Angina’ 
I 
125 
Met Inclusion Criteria* 
/\ 
60 
Chest Pain Resolved 
Prior to Transfer 
65 





Truly Refractory Chest Pain Resolved 
to Maximum on Aggressive 
Medical Therapy Medical Therapy 
‘Inclusion Criteria: 1. Chest pain at rest with reversible ECG changes 
2. Absence of myccardial infarction 
3. Attempted stabilization with medical therapy 
changes persisted with maximal medical therapy, or as 
medically stabilized if chest pain resolved with medical 
therapy. Medically stabilized patients were further clas- 
sified based on subsequent in-hospital treatment strate- 
gy, which included continued medical therapy, coronary 
angioplasty and bypass grafting. In-hospital recurrent 
angina, myocardial infarction or death were recorded 
for each treatment strategy. 
Statistieal analysis: For discrete variables, analysis 
was performed with chi-square tests and for continuous 
variables, Student t tests were used. All group data were 
expressed as mean f 1 SD. A p value <0.05 was con- 
sidered statistically significant. 
RESULTS 
In all, 502 patients with “unstable angina” were 
transferred to the University of Michigan Hospital dur- 
ing the study period (Figure 1). The following groups of 
patients were excluded from this cohort: 17 transferred 
directly for revascularization without attempts at medi- 
cal stabilization; 28 with evidence of myocardial infarc- 
tion; 51 without chest pain at rest; and 281 after review 
of the records did not document reversible electrocar- 
diographic changes with chest pain. Inclusion criteria 
were fulfilled by 125 patients. Chest pain resolved with 
medical therapy in 60 of these patients before transfer. 
Chest pain at rest with ischemic electrocardiographic 
changes continued in 65 patients who were considered 
medically refractory by their referring physicians. A 
more aggressive medical regimen was used at the Uni- 
versity of Michigan, and 54 (83%) of these patients be 
came free of chest pain. Only 11 patients (8.8%) ulti- 
mately proved refractory to maximal medical therapy. 
Demographic and dinieal data: Table I shows char- 
acteristics of the 11 patients with refractory unstable 
angina compared with the 114 who stabilized with med- 
ical therapy. No significant differences were found be 
tween the groups regarding age, sex, history of stable 
angina pectoris or myocardial infarction, and left ven- 
tricular function. Patients with refractory unstable angi- 
na were more likely to have had prior coronary artery 
bypass grafting. Patients with refractory unstable angi- 
na had persistent chest pain despite an average of 9 
days of maximal (5-drug) medical therapy, whereas 
those responding to medical therapy with resolution of 
chest pain did so in an average of 4 days (p = 0.01). 
Patients with refractory unstable angina were more 
likely to have anterior electrocardiographic changes 
with chest pain (7 of 11 vs 25 of 114; p = 0.008). Inferi- 
or electrocardiographic changes with chest pain were 
not seen in the refractory group (p = 0.03). T-wave in- 
version with chest pain was more often seen in patients 
who stabilized on medical therapy (p = 0.05). All pa- 
tients underwent cardiac catheterization. Refractory pa- 
tients had an increased likelihood of left main or 3-ves- 
se1 coronary artery disease (7 of 11 vs 26 of 114; 
p = 0.01). A >70% stenosis of the left main coronary 
artery was identified in 5 of 11 patients in the refractory 
group and in 2 of 114 in the medically stabilized group. 
In-hospital myocardial infarction or death was signifi- 
cantly more frequent in the refractory group (4 of 11 vs 
9 of 114; p = 0.009). 
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TABLE II Comparison of Medical Regimens at Community 
Hospitals and University of Michigan in 65 Patients Considered 
to Have Medically Refractory Unstable Angina at Transfer 
Community 
Hospitals 
(n = 65) 
University of 
Michigan 


































*Drug therapy 1s considered treatment wth combinations of aspirin, Intravenous 
heparin, nitrates, calcium antagonlsts and p blockers. 
compalison of medkal wr: Table II com- 
pares the medical regimens at community hospitals and 
at the University of Michigan in the 65 patients consid- 
ered to have medically refractory unstable angina at the 
time of transfer. Resolution of chest pain at the Univer- 
sity of Michigan was achieved in 54 of 65 patients 
(83%) with more frequent use of aspirin, and intrave- 
nous heparin and nitroglycerin. Multidrug therapy us- 
ing combinations of aspirin, intravenous heparin, ni- 
trates, calcium antagonists and p blockers was also 
more frequent at the University of Michigan (50 of 65 
patients [77%] receiving 4- or 5-drug therapy vs 19 of 
65 [29%] at community hospitals; p = 0.0001). 
Hospital course (refractory unstable angina pa- 
Writs): All 11 patients with refractory unstable angina 
underwent revascularization. Coronary angioplasty was 
performed in 4 patients with refractory angina. One pa- 
tient had abrupt closure and subsequent non-Q-wave 
myocardial infarction. One patient with a large dissec- 
tion of the left anterior descending coronary artery died 
the day after angioplasty with a cardiac arrest. There 
were 7 refractory patients treated with bypass grafting. 
Two patients died after surgery; 1 could not be weaned 
from cardiopulmonary bypass, and 1 died 1 day after 
surgery from ventricular fibrillation. One patient had a 
perioperative myocardial infarction. 
Hospital courw (stabwad pa@nts): The hospital 
course of the 114 medically stabilized patients included 
continued medical therapy in 37, coronary angioplasty 
in 46, and bypass grafting in 31. Table III shows that 
the groups were similar in duration of medical therapy 
before resolution of chest pain, number of drugs used to 
achieve medical stabilization, and left ventricular func- 
tion. Patients with left main or 3-vessel coronary artery 
disease were more likely to undergo bypass grafting 
during hospitalization, whereas those with l- or 2-vessel 
coronary artery disease were more often treated with 
continued medical therapy or coronary angioplasty. 
Table IV shows the hospital course of the 114 pa- 
tients with unstable angina who became free of chest 
pain with medical therapy. Stabilized patients managed 
with continued medical therapy (n = 37) were chest 
TABLE Ill Baseline Characteristics of 114 Patients with 
Unstable Angina Stabilized with Medical Therapy 
In-Hospital Treatment Strategy 
Medical Bypass 
Management Angioplasty Surgery 
tn = 37) fn = 46) tn = 31) 
Days of medical therapy before 4 3 5 
stabilization 
No. of drugs used at stabiliza- 
tion* 
1 to3 17 (46%) 20 (43%) 13 (42%) 
4 or 5 20 (54%) 26 (57%) 18 (58%) 
Coronary artery disease 
l- to 2-vessel 30 (81%) 41(89%) 13 (42%) 
3-vessel or left main 7 (19%) 5 (9%) 18 (58%) 
Ejection fraction 51 * 15 53 2 19 472 11 
Prior bypass coronary surgery 9 (24%) 7 (15%) 3 (10%) 
‘Drug therapy is considered treatment with combinations of aspirin, intravenous 
heparin, nitrates, calcium antagonists and p blockers; values are mean *SD. 
I 
TABLE IV Hospital Course of 114 Patients with Unstable 
Angina Stabilized with Medical Therapy 
In-Hospital Treatment Strategy 
I 
Medical 
Clinical Management Angioplasty Bypass Surgery 
Outcomes (n = 37) (n = 46) fn = 31) 
Myocardial infarction 0 4 (9%) 1 (3%) 
Death 1 (3%) 1(2%) 2 (6%) 
No. of drugs at discharge* 
1 or2 14 (39%) 21 (47%) 18 (58%) 
3 or 4 22 (61%) 24 (53%) 11 (40%) 
*Includescombinations of aspirin, nitrates, calcwm antagonistsand @ blockers. 
pain-free an average of 7 days before discharge. No 
patient in this group had a myocardial infarction and 1 
(2.7%) died during hospitalization. Recurrent stable an- 
gina developed in 3 patients (8.1%) and was controlled 
by alterations in medical therapy. 
Coronary angioplasty was performed in 46 medical- 
ly stabilized patients before discharge. Indications for 
coronary angioplasty included: (1) coronary anatomy 
considered high risk for future cardiac events (n = 42; 
91%); (2) ischemia on prediicharge exercise testing 
(n = 3; 6.7%); and (3) recurrent exertional angina 
(n = 1; 2.2%). Coronary angioplasty was performed an 
average of 6 days after the onset of unstable angina and 
4 days after the last episode of chest pain. Angioplasty 
was successful in 92% of cases. Abrupt closure compli- 
cated 12 of 46 procedures (26%). Emergency bypass 
grafting was needed in 3 patients (6.5%), 4 (8.7%) had 
postprocedural myocardial infarction, and 1 (2.2%) died 
after angioplasty. After angioplasty, the incidence of 
emergency bypass grafting, myocardial infarction or 
death was 17%. 
Bypass grafting was performed in 31 medically sta- 
bilized patients before discharge. Indications for surgery 
included: (1) coronary anatomy considered high risk for 
future cardiac events (n = 26; 84%); (2) ischemia on 
predischarge exercise testing (n = 2; 6%); and (3) recur- 
rent exertional angina (n = 3; 10%). One patient had a 
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perioperative myocardial infarction, and there were 2 
deaths after surgery. 
Myocardial infarction or death occurred in 3% of 
patients managed medically, in 11% treated with coro- 
nary angioplasty and in 9% who underwent bypass 
grafting. Patients revascularized by coronary angio- 
plasty or bypass grafting tended to be discharged with 
less medical therapy. 
DISCUSSION 
Atherosclerotic plaque rupture with concomitant 
platelet aggregation and thrombus formation is believed 
to be the underlying mechanism for the development of 
acute coronary syndromes7y8 Most studies assessing 
morbidity and mortality in patients hospitalized with 
unstable angina were performed before routine use of 
intravenous heparin and aspirin. Conventional therapy 
of patients hospitalized with unstable angina with ni- 
trates, fl blockers or calcium antagonists reduces the 
number of ischemic episodes, but does not reduce the 
frequency of myocardial infarction (13%) or death 
(4%).9-l3 Both aspirin3,4J2J3 and intravenous heparin3,4 
have been shown to reduce the rate of myocardial in- 
farction and death in patients hospitalized with unstable 
angina. 
Gur findings show that “true” refractory unstable 
angina is infrequent (<9%) with aggressive contempo- 
rary medical therapy, including combinations of antian- 
ginal, anticoagulant and antiplatelet agents. Theroux et 
al3 showed a 23% incidence of refractory angina in pa- 
tients hospitalized with resting or accelerating angina 
managed with nitrates, /3 blockers or calcium antago- 
nists. When intravenous heparin with or without aspirin 
was used, a 9.6% incidence of refractory angina was ob- 
served. Most patients in our study considered medically 
refractory at transfer were medically undertreated. 
Of patients considered medically refractory who were 
transferred to our hospital for urgent revasculariza- 
tion, most (83%) became free of chest pain on a more 
aggressive medical regimen. Only one third of these 
pseudorefractory patients were receiving intravenous 
heparin, and surprisingly, 30% were not receiving aspi- 
rin therapy. 
Persistence of chest pain in patients hospitalized 
with unstable angina despite maximal medical therapy 
predicts a poor outcome, with a 51% incidence of early 
infarction or death.14 All refractory patients in this 
study underwent revascularization by either coronary 
angioplasty or bypass grafting. However, a 36% rate of 
in-hospital myocardial infarction or death was still ob- 
served. 
The hospital treatment strategies for medically sta- 
bilized patients included continued medical manage- 
ment, coronary angioplasty and bypass grafting. Several 
prior studies showed that patients with unstable angina 
who become chest pain-free with medical therapy have 
a low rate of in-hospital cardiac events, with a 1 to 2% 
mortality rate and a 7 to 9% rate of myocardial infarc- 
tion.i4J5 In the study by Theroux et al3 and the Re- 
search Group on Instability in Coronary Artery Disease 
in Southeast Sweden (RISC) trial,4 the use of intrave- 
nous heparin and aspirin in combination with antiangi- 
nal therapy in the treatment of patients hospitalized 
with unstable angina resulted in a 1.5% rate of myocar- 
dial infarction or death. Medically stabilized patients in 
our study whose treatment strategy consisted of contin- 
ued medical therapy had a low rate (30%) of in-hospital 
myocardial infarction or death. Rapid progression of 
the underlying coronary stenosis is known to occur in 
most patients after an episode of unstable angina, with 
30 to 50% redeveloping angina and crossing over to re- 
vascularization by 1 year. l6 Frequently cited predictors 
of poor long-term outcome in patients with unstable an- 
gina managed medically include left main or 3-vessel 
coronary artery disease, decreased left ventricular func- 
tion, abnormal baseline electrocardiogram, prior myo- 
cardial infarction, reperfusion abnormality on thallium 
imaging, and silent ischemia on continuous ambulatory 
monitoring.17-20 Thus, although most patients hospital- 
ized with unstable angina do not need urgent revascu- 
larization for relief of chest pain, recurrent angina1 
symptoms after discharge are common. 
Coronary angioplasty within the first 1 to 2 weeks 
after the onset of unstable angina has an increased com- 
plication rate.5p16,21-26 Angioplasty in this setting of 
intraluminal thrombus2’ carries a significantly higher 
rate of abrupt closure.28 A review of the studies of coro- 
nary angioplasty in unstable angina shows a major com- 
plication rate (myocardial infarction, emergent bypass 
grafting or death) of 10 to 26%.5J6J1-26 Treatment of 
these patients with 3 to 5 days of intravenous heparin in 
preparation for coronary angioplasty may decrease this 
complication rate.29j0 Myler et al5 found that angio- 
plasty in patients within the first 2 weeks after the onset 
of unstable angina is associated with a lower initial suc- 
cess rate and a two to threefold increased risk for myo- 
cardial infarction, need for emergency bypass grafting, 
death or development of late recurrent angina. The high 
complication rate and poor outcome for coronary angio- 
plasty in patients with unstable angina in our study 
(26% abrupt closure rate, and 17% incidence of myocar- 
dial infarction, emergency bypass grafting or death) 
supports the contention that early coronary angioplasty 
in unstable angina has a complication event rate that 
may exceed the natural history of adverse cardiac 
events occurring in this population when managed con- 
servatively with medical therapy.23 An increased opera- 
tive mortality has also been reported when coronary ar- 
tery bypass grafting is performed in patients with unsta- 
ble angina.6 The rate of myocardial infarction or death 
in this study for medically stabilized patients undergo- 
ing bypass grafting before hospital discharge was 9%. 
Comparisons between treatment strategies (medical 
management, coronary angioplasty and bypass graft- 
ing) of the medically stabilized patients are not possible, 
because of the retrospective nature of this study. Be- 
cause our hospital serves as a referral center, the char- 
acteristics of patients with unstable angina in this study 
may differ from those presenting to other hospitals. 
Furthermore, with the inclusion criteria selecting only 
patients with prolonged angina at rest and electrocar- 
diographic changes, the high complication rate of coro- 
nary angioplasty may not reflect the results of angio- 
plasty in patients with new-onset or accelerating unsta- 
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ble angina pectoris. Finally, the data are limited by the 
absence of long-term follow-up and thus only provide a 
“window” of the acute phase of this clinical syndrome. 
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